MARKET

VIVO

VIVO

Meridian Biosci
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.15
+0.21
+1.11%
Opening 12:12 07/23 EDT
OPEN
18.96
PREV CLOSE
18.94
HIGH
19.27
LOW
18.71
VOLUME
239.50K
TURNOVER
--
52 WEEK HIGH
30.65
52 WEEK LOW
12.98
MARKET CAP
829.77M
P/E (TTM)
9.61
1D
5D
1M
3M
1Y
5Y
BRIEF-Meridian Signs Deal To Buy Urea Breath Test For H. Pylori From Otsuka America Pharmaceutical
reuters.com · 2h ago
Meridian Bioscience to acquire North American BreathTek business from Otsuka
Meridian Bioscience ([[VIVO]]) has signed a definitive agreement to acquire the North American BreathTek business from Otsuka America Pharmaceutical for $20M in cash.The transaction is expected to close in Meridian’s
Seekingalpha · 2h ago
Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.
CINCINNATI, July 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it signed a definitive agreement to acquire the North American BreathTek...
GlobeNewswire · 2h ago
Meridian Bioscience to Acquire Otsuka's North American BreathTek Business for $20 Million
MT Newswires · 6h ago
Bullish Trend Continues In Cannabis Market: Tilray, Canopy Growth & GrowGen Among Top Cannabis Movers For July 21, 2021
GAINERS: Flower One Hldgs (OTC: FLOOF) shares closed up 17.57% at $0.15
Benzinga · 1d ago
Investors Shouldn't Overlook The Favourable Returns On Capital At Meridian Bioscience (NASDAQ:VIVO)
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
Simply Wall St. · 2d ago
Bearish Sentiment Toward Market: Cannabis Movers For July 19, 2021
GAINERS: Livewell Canada Inc (OTC: LMLLF) shares closed up 12.87% at $0.06
Benzinga · 3d ago
C21 Investments, 1933 Industries And Urban-Gro Among Top Cannabis Stock Movers On June 16, 2021
GAINERS: Heritage Cannabis Holding (OTC: HERTF) shares closed up 9.12% at $0.07ª
Benzinga · 6d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VIVO. Analyze the recent business situations of Meridian Biosci through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average VIVO stock price target is 29.67 with a high estimate of 34.00 and a low estimate of 25.00.
EPS
Institutional Holdings
Institutions: 311
Institutional Holdings: 48.23M
% Owned: 111.30%
Shares Outstanding: 43.33M
TypeInstitutionsShares
Increased
69
2.72M
New
45
4.75M
Decreased
74
4.08M
Sold Out
21
1.03M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.83%
Healthcare Equipment & Supplies
+0.85%
Key Executives
Non-Executive Chairman/Independent Director
David Phillips
Chief Executive Officer/Director
John Kenny
Chief Financial Officer/Executive Vice President/Chief Accounting Officer/Secretary
Bryan Baldasare
Executive Vice President
Tony Serafini-Lamanna
Executive Vice President
Lourdes Weltzien
Independent Director
James Anderson
Independent Director
Anthony Bihl
Independent Director
Dwight Ellingwood
Independent Director
John McIlwraith
Independent Director
John Rice
Independent Director
Catherine Sazdanoff
Independent Director
Felicia Williams
Declaration Date
Dividend Per Share
Ex-Div Date
01/22/2019
Dividend USD 0.125
02/01/2019
11/07/2018
Dividend USD 0.125
11/16/2018
07/24/2018
Dividend USD 0.125
08/09/2018
04/25/2018
Dividend USD 0.125
05/04/2018
01/24/2018
Dividend USD 0.125
02/02/2018
11/08/2017
Dividend USD 0.125
11/17/2017
07/25/2017
Dividend USD 0.125
08/03/2017
04/25/2017
Dividend USD 0.125
05/04/2017
01/25/2017
Dividend USD 0.125
02/02/2017
11/09/2016
Dividend USD 0.2
11/17/2016
07/26/2016
Dividend USD 0.2
08/04/2016
04/26/2016
Dividend USD 0.2
05/05/2016
01/26/2016
Dividend USD 0.2
02/04/2016
11/04/2015
Dividend USD 0.2
11/12/2015
07/21/2015
Dividend USD 0.2
07/30/2015
04/21/2015
Dividend USD 0.2
04/30/2015
01/21/2015
Dividend USD 0.2
01/29/2015
11/05/2014
Dividend USD 0.2
11/13/2014
07/22/2014
Dividend USD 0.2
07/31/2014
04/22/2014
Dividend USD 0.2
05/01/2014
About VIVO
Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.

Webull offers kinds of Meridian Bioscience, Inc. stock information, including NASDAQ:VIVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VIVO stock methods without spending real money on the virtual paper trading platform.